-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Monte Rosa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to Q3 2025.
- Monte Rosa Therapeutics, Inc. Depreciation for the quarter ending September 30, 2025 was $2.1M, a 0.38% decline year-over-year.
- Monte Rosa Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2025 was $8.33M, a 5.35% increase year-over-year.
- Monte Rosa Therapeutics, Inc. annual Depreciation for 2024 was $8.12M, a 30.5% increase from 2023.
- Monte Rosa Therapeutics, Inc. annual Depreciation for 2023 was $6.22M, a 66.1% increase from 2022.
- Monte Rosa Therapeutics, Inc. annual Depreciation for 2022 was $3.75M, a 75.7% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)